Battling Antimicrobial Resistance in Northwest Syria: A Call for Urgent Action

By Melike Belenli Gümüş

November 26, 2024

Antimicrobial resistance (AMR) poses a significant threat to global health. A recent article from the World Health Organization’s Eastern Mediterranean Regional Office (EMRO) enlighten the critical issue of antimicrobial resistance (AMR) and the important role of healthcare workers in northwest Syria. It highlights the urgent call from Syrian health professionals for action ahead of World Antimicrobial Awareness Week. Understanding the intricacies of antibiotic usage, the advantages and disadvantages, as well as the burden of AMR, is essential in this challenging context.

Balancing the Benefits and Risks of Antibiotic Use in Conflict Zones

Antibiotics are vital for treating bacterial infections and they are crucial in emergency care, especially in conflict-affected areas like northwest Syria. However, their misuse and overuse, such as purchasing without prescriptions or not completing treatment courses, accelerate AMR. The lack of diagnostic tools in these regions often leads healthcare workers to rely on broad-spectrum antibiotics, further increasing the risk of AMR.

Understanding Antimicrobial Resistance

Antimicrobial resistance occurs when bacteria evolve to resist the effects of antibiotics. This resistance complicates treatments and endangers lives. Dr Mohammad Wahid Rajab Bek, Head of the Syrian Association of Infectious Diseases, highlights the misuse of antibiotics as a leading cause. “Antibiotics are lifesaving when used properly, but misuse has become widespread,” he warns. Many people self-prescribe antibiotics for common colds and fevers, exacerbating the problem.

The Economic and Health Impacts

The financial burden of AMR is substantial. Dr Bek notes a troubling rise in antibiotic-resistant urinary tract infections. “Infections once easily treatable now require stronger, more expensive drugs,” he explains. Treatment costs can soar from US$ 15–US$ 20 to US$ 500–US$ 1000, overwhelming health systems and patients alike. Beyond financial strain, resistant infections lead to prolonged illnesses and weakened immune systems. “Even minor infections can escalate into severe complications or death if unresponsive to antibiotics,” Dr Bek warns.

Strategies to Combat AMR

To address AMR, hospitals have implemented strict antibiotic controls. “Awareness is key,” stresses Dr Bek. Antibiotics are dispensed through a controlled system with specialist consultation. Preventive measures, such as administering specific antibiotics before surgeries, are also emphasised. Patients play a crucial role in this battle. Completing the prescribed course is essential, even if symptoms improve.

A Global Call to Action

World AMR Awareness Week (WAAW) is a global campaign to raise awareness about AMR and promote responsible antimicrobial use. This year, the World Health Organization (WHO), in partnership with the Food and Agriculture Organization (FAO), the UN Environment Programme (UNEP), and the World Organization for Animal Health (WOAH), has developed a campaign guide. This collaboration highlights the need for a united front against AMR and encourages all sectors to participate.

Antimicrobial resistance is a pressing global health issue that demands immediate attention. By educating ourselves and advocating for responsible antibiotic use, we can act now to safeguard future generations. Let us work together to combat antimicrobial resistance and ensure a healthier world for all.

Reference url

Recent Posts

allopurinol Marfan syndrome orphan
       

Allopurinol Designated an Orphan Drug for Marfan Syndrome

🌟 What does the EMA’s orphan drug designation for allopurinol mean for those impacted by Marfan syndrome?

This groundbreaking move highlights a significant step forward in tackling rare diseases, offering hope to patients with limited treatment options. Allopurinol, traditionally used for gout, shows promise in addressing life-threatening aortic complications associated with Marfan syndrome, thanks to its antioxidant properties.

Dive into the implications of this development for healthcare innovation, patient access, and the future of rare disease treatment!

#SyenzaNews #HealthEconomics #Innovation #MarketAccess

marstacimab hemophilia B
                

NICE’s Approval of Marstacimab for Hemophilia B: Transforming Treatment Landscapes and Economic Implications

💡 Are we witnessing a paradigm shift in hemophilia treatment?

The recent recommendation from NICE for marstacimab as a novel therapy for severe hemophilia B is a game-changer. With its ability to provide effective prophylaxis while potentially lowering treatment costs, this could reshape patient care and health economics in this space.

Dive into the implications this has for patients and healthcare providers, and why marstacimab’s approval could be a pivotal moment for hemophilia management.

Explore the full article for deeper insights!

#SyenzaNews #HealthEconomics #HealthcareInnovation #MarketAccess

HPV-related cancer trends
    

HPV-Related Cancer Trends in South Africa 2011-2021

🌍 Are we witnessing a rise in HPV-related cancer in South Africa?

A recent analysis of data from the South African National Cancer Registry highlights concerning trends: while cervical cancer rates are declining, there’s an alarming rise in non-cervical anogenital cancers. This underscores the urgent need for enhanced cancer prevention and access to efficient healthcare services in the country.

Dive into the findings and explore the implications for health systems and policies.

#SyenzaNews #HealthEconomics #HealthcareInnovation #GlobalHealth

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.